Skip to main content

Table 3 Laboratory findings of patients with organophosphate poisoning, stratified according to diabetes mellitus status (N = 118)

From: Acute large-dose exposure to organophosphates in patients with and without diabetes mellitus: analysis of mortality rate and new-onset diabetes mellitus

Variable (mean ± SD)

Total (N = 118)

Non–diabetes mellitus (N = 109)

Diabetes mellitus (N = 9)

P

Hemoglobin, g/dL

14.33 ± 1.91

14.37 ± 1.95

13.81 ± 1.30

0.428

Blood urea nitrogen, mg/dL

16.74 ± 16.45

16.34 ± 16.71

25.20 ± 4.53

0.463

Creatinine, mg/dL

1.06 ± 0.72

1.05 ± 0.74

1.14 ± 0.47

0.741

Sodium, mEq/L

140.97 ± 3.68

141.04 ± 3.72

140.13 ± 3.40

0.502

Potassium, mEq/L

3.50 ± 0.54

3.48 ± 0.51

3.75 ± 0.76

0.167

Cholinesterase (initial), U/mL

3.29 ± 3.53

3.18 ± 3.24

4.67 ± 6.31

0.254

Cholinesterase (lowest), U/mL

2.79 ± 3.06

2.65 ± 2.65

4.65 ± 6.28

0.400

C-reactive protein, mg/dL

8.18 ± 18.67

8.13 ± 19.31

8.77 ± 15.65

0.616

Amylase, U/L

195.98 ± 167.47

197.62 ± 162.72

176.18 ± 187.21

0.910

Lipase, U/L

113.50 ± 115.10

113.89 ± 117.96

108.74 ± 84.24

0.365

CK-MB, ng/mL

17.98 ± 61.03

17.56 ± 64.77

23.07 ± 48.23

0.691

Troponin-I, ng/mL

0.07 ± 0.13

0.08 ± 0.14

0.05 ± 0.12

0.618

QT interval, ms

369.07 ± 57.59

366.61 ± 58.56

390.57 ± 46.20

0.301

QTc interval, ms

443.18 ± 52.71

440.21 ± 52.96

479.29 ± 53.52

0.236

  1. SD, standard deviation; CK-MB, creatinine kinase MB; QTc, corrected QT interval.